Surgical Oncology
Volume 15, Issue 1 , Page 58 , July 2006

Allergic reactions to patent blue dye

References 

  1. Beenen E, de Roy van Zuidewijn DB. Patients blue on patent blue: an adverse reaction during four sentinel node procedures. Surgical Oncology. 2006;
  2. Dewachter P, Mouton-Faivre C, Trechot P, Lleu JC, Mertes PM. Severe anaphylactic shock with methylene blue instillation. Anesthesia and Analgesia. 2005;101(1):149–150table
  3. Simmons RM, Smith SM, Osborne MP. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Breast Journal. 2001;7(3):181–183
  4. Eldrageely K, Vargas MP, Khalkhali I, Venegas R, Burla M, Gonzalez KD, et al. Sentinel lymph node mapping of breast cancer: a case–control study of methylene blue tracer compared to isosulfan blue. American Surgeon. 2004;70(10):872–875
  5. Nour A. Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients. Breast Journal. 2004;10(5):388–391
  6. Salhab M, Al Sarakbi W, Mokbel K. Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer. International Seminars in Surgical Oncology. 2005;2:26
  7. Stradling B, Aranha G, Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. American Journal of Surgery. 2002;184(4):350–352
  8. Singh-Ranger G, Mokbel K. Capsular contraction following immediate reconstructive surgery for breast cancer—an association with methylene blue dye. International Seminars in Surgical Oncology. 2005;1(3):1–3
  9. Stradling B, Aranha G, Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. American Journal of Surgery. 2002;184(4):350–352

PII: S0960-7404(06)00023-5

doi: 10.1016/j.suronc.2006.06.002

Surgical Oncology
Volume 15, Issue 1 , Page 58 , July 2006

Article Tools